Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Cantel Medical Corp.

http://www.cantelmedical.com/

Latest From Cantel Medical Corp.

Oxurion Eyes $12bn Opportunity After Restructuring

The Belgium-headquartered group is pulling the plug on its dry AMD research efforts and investments in cancer venture Oncurious to focus on two early-stage compounds that show promise for diabetic macular edema and other retinal diseases.

Ophthalmic Business Strategies

Dealmaking Quarterly Statistics, Q1 2021: Boston Scientific, Roche Start The Year With Billion-Dollar-Plus Acquisitions

During the first quarter, medical device company mergers and acquisition totalled $10.2bn, while in vitro diagnostic firms and research tools players completed M&A activity that totaled $5bn.

M & A Deals

Cardinal Agrees To Sell Cordis For $1Bn To Hellman & Friedman

Cardinal said it remains “committed to its medical distribution and global medical products businesses” despite the divesture of Cordis.

Financing Cardiovascular

Riding On Exosome Potential, Evox Eyes Unicorn Status

A financing round that was significantly oversubscribed by new and existing investors will help advance the Oxford-headquartered biotech's exosome therapeutics into the clinic and expand its technology platform.

Financing Strategy
See All

Company Information

  • Industry
  • Medical Devices
    • Infection Control-Sterilization
  • Other Names / Subsidiaries
    • Accutron, Inc.
    • Aexis Medical BVBA
    • Hu-Friedy Corporation
    • JetPrep Ltd.
    • Medical Innovations Group Holdings Limited,
UsernamePublicRestriction

Register